Search details
1.
The Emerging Role of MAIT Cell Responses in Viral Infections.
J Immunol
; 211(4): 511-517, 2023 08 15.
Article
in English
| MEDLINE | ID: mdl-37549397
2.
Gag p24 Is a Marker of Human Immunodeficiency Virus Expression in Tissues and Correlates With Immune Response.
J Infect Dis
; 224(9): 1593-1598, 2021 11 16.
Article
in English
| MEDLINE | ID: mdl-33693750
3.
Defining T Cell Tissue Residency in Humans: Implications for HIV Pathogenesis and Vaccine Design.
Curr HIV/AIDS Rep
; 17(2): 109-117, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32052270
4.
Increases in HIV Incidence Following Receptive Anal Intercourse Among Women: A Systematic Review and Meta-analysis.
AIDS Behav
; 24(3): 667-681, 2020 Mar.
Article
in English
| MEDLINE | ID: mdl-31486008
5.
Differential Expression of CD8+ T Cell Cytotoxic Effector Molecules in Blood and Gastrointestinal Mucosa in HIV-1 Infection.
J Immunol
; 200(5): 1876-1888, 2018 03 01.
Article
in English
| MEDLINE | ID: mdl-29352005
6.
HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.
PLoS Pathog
; 10(5): e1004078, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24831517
7.
Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers.
PLoS Pathog
; 9(10): e1003691, 2013.
Article
in English
| MEDLINE | ID: mdl-24130489
8.
Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection.
Blood
; 121(7): 1124-35, 2013 Feb 14.
Article
in English
| MEDLINE | ID: mdl-23243281
9.
The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial.
Blood
; 121(23): 4635-46, 2013 Jun 06.
Article
in English
| MEDLINE | ID: mdl-23589670
10.
First-in-human immunoPET imaging of COVID-19 convalescent patients using dynamic total-body PET and a CD8-targeted minibody.
medRxiv
; 2023 Mar 20.
Article
in English
| MEDLINE | ID: mdl-36993568
11.
First-in-human immunoPET imaging of COVID-19 convalescent patients using dynamic total-body PET and a CD8-targeted minibody.
Sci Adv
; 9(41): eadh7968, 2023 10 13.
Article
in English
| MEDLINE | ID: mdl-37824612
12.
Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers.
J Virol
; 85(21): 11422-34, 2011 Nov.
Article
in English
| MEDLINE | ID: mdl-21880771
13.
Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection.
BMC Complement Altern Med
; 12: 84, 2012 Jun 29.
Article
in English
| MEDLINE | ID: mdl-22747752
14.
A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response.
J Infect Dis
; 203(7): 960-8, 2011 Apr 01.
Article
in English
| MEDLINE | ID: mdl-21402547
15.
Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.
J Virol
; 84(19): 10354-65, 2010 Oct.
Article
in English
| MEDLINE | ID: mdl-20668079
16.
HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses.
J Virol
; 84(21): 11020-9, 2010 Nov.
Article
in English
| MEDLINE | ID: mdl-20719952
17.
Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS.
J Virol
; 84(6): 2913-22, 2010 Mar.
Article
in English
| MEDLINE | ID: mdl-20032180
18.
Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control.
Blood
; 113(17): 3978-89, 2009 Apr 23.
Article
in English
| MEDLINE | ID: mdl-19109229
19.
The Role of Tissue Resident Memory CD4 T Cells in Herpes Simplex Viral and HIV Infection.
Viruses
; 13(3)2021 02 25.
Article
in English
| MEDLINE | ID: mdl-33668777
20.
Reproductive tract immune cells from pregnant women or those using depot medroxyprogesterone acetate show no excess susceptibility to HIV-1: Results of an ex vivo fusion assay.
Contraception
; 103(1): 44-47, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33007299